Advances in aetiology, epidemiology, and pathophysiology have extended therapy choices, resulting in the agitation in the delirium management market market making significant progress in recent years. Antipsychotics like haloperidol, risperidone, and olanzapine, as well as benzodiazepines like midazolam and lorazepam, are among the first-line treatments for individuals with agitated agitation. First-generation antipsychotics, second-generation antipsychotics, and benzodiazepines are some of the important product categories in the agitation in delirium therapy
First-generation antipsychotics, second-generation antipsychotics, and benzodiazepines are some of the important product categories in the Agitation In Delirium Management market. Retail pharmacies, online pharmacies, and hospital pharmacies are all important distribution routes.
Delirium can be induced by a variety of reasons, including alcohol misuse, drug exposure, advanced age, surgery or other medical procedures, and dietary, physical trauma, viral or toxic agent exposure, and other occupational and behavioural factors. Delirium is divided into two types: hypoactive delirium and hyperactive delirium. In hyperactive delirium, patients become agitated (agitation in delirium). As a result, there is a growing demand for novel drugs to treat agitation in delirium.
Read More@ https://bit.ly/3qVPBtg
